Related Experiment Video
Updated: Apr 25, 2026
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
[Antiplatelet therapy after drug-eluting stent implantation]
Insights
Preventing stent thrombosis after drug-eluting stent (DES) implantation involves careful patient selection, optimal stent sizing, and appropriate dual antiplatelet therapy (DAPT) duration. Balancing thrombosis prevention with bleeding risk is crucial for patient outcomes.
Area of Science:
- Cardiovascular Interventions
- Interventional Cardiology
- Biomedical Engineering
Context:
- Stent thrombosis remains a critical complication following percutaneous coronary intervention (PCI).
- Optimizing drug-eluting stent (DES) implantation strategies is essential for improving patient safety.
- Current guidelines emphasize the need for individualized treatment plans to mitigate risks.
Purpose:
- To outline a comprehensive strategy for preventing stent thrombosis in patients undergoing DES implantation.
- To highlight key considerations for patient selection, stent deployment, and post-procedural management.
- To emphasize the importance of balancing antithrombotic benefits against bleeding risks.
Summary:
- Prophylaxis strategies include selecting patients with low bleeding risk and good adherence, utilizing next-generation DES, and employing advanced imaging (IVUS, OCT) for optimal stent sizing and deployment.
- Ensuring adequate stent expansion and avoiding edge dissections during high-pressure balloon inflation are critical procedural steps.
- Dual antiplatelet therapy (DAPT) duration should be individualized, ideally at least 12 months, considering patient-specific factors like drug resistance and bleeding risk.
Impact:
- Implementation of these strategies can significantly reduce the incidence of life-threatening stent thrombosis.
- Personalized DAPT regimens can optimize therapeutic efficacy while minimizing hemorrhagic complications.
- Improved stent thrombosis prophylaxis contributes to better long-term outcomes for patients undergoing PCI.
Abstract:
Stent thrombosis is a lethal complications and most important unresolved issues of the current PCI. For stent thrombosis prophylaxis of DES implantation patient, there is not a plan of surgery within six months at least, bleeding risk is low, to select patients with good adherence, and a new generation of low-thrombosis DES when implanted select the DES, and then select the appropriate stent size, the length using IVUS, OCT, the FFR, and without creating a dissection at the edges in the high-pressure expansion, and perform sufficient expansion, DAPT after surgery is at least 12 months it is desirable, but it is necessary to consider the balance of the benefit of thrombosis prophylaxis and risk of bleeding DES implantation site, the patient, to determine drug resistance, drug combination be considered in individual cases the selection DAPT period, the single agent.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:27Peripheral Artery Disease III: Interprofessional Care
01:27Coronary Artery Disease V: Interprofessional Care
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Angina IV: Management